Cipla receives USFDA nod for cancer drug

The US health authorities on Wednesday approved Lenalidomide capsule, a medication used to treat many forms of cancer, according to […]

By Elets News Network

Dr Reddy’s Laboratories, Cipla Join Hands to Invest in ABCD Technologies

Drug giants Dr Reddy’s Laboratories and Cipla have informed that they have joined hands for a partnership agreement with ABCD […]

By Elets News Network

Cipla launches rapid antigen test kits for quick detection of COVID-19

Drug major Cipla has made has announced its partnership with the Premier Medical Corporation Pvt Ltd for commercialisation of the […]

By Elets News Network

Cipla launches “Covi-G” for COVID-19 rapid antibody detection

Cipla Limited has announced that it signed a licensing agreement with a Belgium-based firm, Multi G for the distribution of […]

By Elets News Network

Gilead Sciences signs licensing agreement with Cipla for potential COVID-19 treatment drug

A licensing agreement has been signed between Cipla, a homegrown pharma major and Gilead Sciences Inc on investigational drug remdesivir, […]

By Elets News Network

Cipla acquires brand, trademark rights for anti-diabetic drug Vysov in India

Homegrown pharma major Cipla Ltd has acquired brand name and trademark rights for Vysov for anti-diabetic drug Vildagliptin for the […]

By Elets News Network

Cipla acquires anti-infective product Elores from Venus Remedies

Pharma major Cipla has acquired a novel and patented anti-infective product, Elores, from Venus Remedies Ltd (VRL) for the Indian […]

By Elets News Network

‘Pharma cos received notice for introducing drugs without NPPA’s nod’

Cipla, Dr Reddy’s, and Lupin, are among pharma companies which got notice for launching drugs in the market without taking […]

By Elets News Network

Cipla, Jiangsu Acebright form joint venture for respiratory medicines in China

A joint venture has been formed between Indian pharma major Cipla Jiangsu Acebright Pharmaceutical Co Ltd An agreement has been […]

By Elets News Network

Dr Raju Mistry takes reins as Global Chief People Officer in Cipla

Global pharmaceutical company Cipla has appointed Dr Raju Mistry as President and Global Chief People Officer (GCPO) of the company. […]

By Elets News Network

Cipla Medpro plans to acquire 30% stake in Brandmed Ltd

Cipla Medpro, a wholly-owned subsidiary of Cipla Limited and South Africa’s third largest pharmaceutical company in the private sector, will […]

By Elets News Network

Cipla inks $22 mn agreement with Pulmatrix Inc for asthma drug

Cipla has signed a binding agreement with Pulmatrix Inc for co-development and licensing opportunity for a new asthma drug under […]

By Elets News Network

Cipla to acquire 11.71% stake in Wellthy Therapeutics

In a bid to acquire the minority stake in the Mumbai-based firm for a cash consideration of Rs 10.5 crore, […]

By Elets News Network